These two new drugs for Alzheimer disease, presented at AAN 2015, are too good not to review. Here, a 6-slide summary of aducanumab and encenicline studies.
UBM organizes over 300 market-leading B2B events every year. At our events, we create the environments which allow business to flourish. Our knowledge of the communities we serve, our ability to attract the right people and our skill at curating the physical space and creating memorable experiences bring thousands of like-minded people together.